01 3BOEHRINGER INGELHEIM
01 311564886
01 3Blank
01 3Y
01 32032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 11564886
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-3531
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 11564886
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-3531
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
Patent Expiration Date : 2032-03-07
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 11564886
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-3531
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-03-07
